Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a division of Stemina,…
Exact Sciences announced today that approximately 40,000 Cologuard tests were completed in the first quarter of 2016. “Our first quarter performance reflects sequential growth and another significant year-over-year increase, the result…
Greg Piefer is ambitious, to say the least. The CEO of SHINE Medical Technologies expects his company to create a reliable supply of the medical ingredients, including molybdenum-99, required by nearly…
Cellectar Biosciences‘ public offering raised $8 million, the company announced today. “We are pleased with the results of this offering, including the underwriter’s exercise of their full over-allotment option,” Cellectar…
To improve adherence and care management for people living with COPD and asthma, Propeller Health today announced it will partner with global pharmaceutical company Boehringer Ingelheim. “We are excited to…
SHINE Medical Technologies has received approval from the U.S. Nuclear Regulatory Commission (NRC) for construction of a 57,000 square-foot isotope manufacturing facility in Janesville, Wis., the company announced today. “This is the…
Exact Sciences’ Cologuard will now be covered as an in-network service for patients of Anthem BlueCross of California, the organization announced today. “This is a major milestone for members of Anthem…
Cellular Dynamics International announced Tuesday that it will supply Roche with induced pluripotent stem cell (iPSC)-derived iCell products. According to a release, Roche will have exclusive access to specific iCell products to be employed…
Exact Sciences is staying on the west side. The biotech company is planning to expand its footprint at its current headquarters at University Research Park rather than expand downtown, according…
Pointcare Genomics Corporation announced this week it is the recipient of a $300,000 SBIR Phase I grant. According to a release, the money from the National Cancer Institute will help develop…
